title: Cyclophosphamide or chlorambucil therapy is indicated in idiopathic membranous nephropathy with strong risk factors for progression.
authors.forename: Lee A
authors.initials: LA
authors.lastname: Hebert
authors.forename: Brad H
authors.initials: BH
authors.lastname: Rovin
authors.forename: Anil K
authors.initials: AK
authors.lastname: Agarwal
authors.forename: Dan N
authors.initials: DN
authors.lastname: Spetie
mesh_terms: D002699:Chlorambucil / Q000008:administration & dosage / Q000627:therapeutic use*; D003404:Creatinine / Q000097:blood; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use*; D018450:Disease Progression; D004359:Drug Therapy, Combination; D015433:Glomerulonephritis, Membranous / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000517:prevention & control*; D011507:Proteinuria / Q000209:etiology; D012074:Remission Induction; D012307:Risk Factors
chemical_list: D007166:Immunosuppressive Agents; D002699:Chlorambucil; D003520:Cyclophosphamide; D003404:Creatinine